Advancing Cancer Treatment Through Research & Innovation
Our research focuses on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Current Research Projects
Our current research projects are focused on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Efficacy of Compression Therapy for Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients with Early Breast Cancer: Insights from a Single-Centre Experience in Bangladesh
Prospective
Research Objectives:
- • Incidence of CTCAE version 5 grade 2 or higher CIPN in both upper and lower extremities during entire period of chemotherapy.
The Efficacy of Pembrolizumab for Treatment of Early Triple Negative Breast Cancer: A Single-center, Open, Randomized Controlled Trial
Primary endpoints: A) Pathological Complete Response at the time of definitive surgery B) Event-free survival in the intention-to-treat population Secondary endpoints: Overall survival at the end of 15 months
Research Objectives:
- • A prospective study to measure the efficacy of Pembrolizumab in Early Triple Negative Breast Cancer (TNBC) patients of Bangladeshi population.
Recent Publications
Peer-reviewed research contributions published in leading oncology journals, advancing the field of cancer treatment.
Genomic Alterations in Advanced Lung Cancer Patients Compared via CGP and Hotspot Panel Test in a Bangladeshi Tertiary Hospital
In this retrospective observational study, the preliminary data were collected from hospital information system containing 4435 oncology OPD cases. Genomic alteration data were collected from test reports of 62 advanced …
Key Findings:
Among 4435 oncology OPD cases, 760 (17.1%) cases were of primary lung cancer, and 76% were presented in stage III-IV. CGP identified more actionable genomic …
Childhood Sacrococcygeal Teratoma: A Histopathological Study
The study included 66 patients of SCT operated from 2015 to 2021. A retrospective review of different clinical information and histopathological findings was done from the radiological and pathological records …
Key Findings:
There were 44 females and 22 males with age ranging from newborn to 08 years. Forty two children (63%) presented in the neonatal age group. …
Pattern of Practices of Oncologists of Bangladesh in the COVID-19 Era
This was a cross-sectional survey-type study, based on a questionnaire, which was shared via email to national oncologists and enhanced by snowballing in April–May 2020.
Key Findings:
A total of 48 responders joined the survey, mostly clinical and radiation oncologists practicing in specialized cancer centers of the major cities. Patients’ triage for …
Showing 7 to 9 of 19 publications
Conference Presentations & Speaking Engagements
Sharing research findings and clinical insights at leading medical conferences worldwide.
ESMO Asia 2025
Clinicopathological pathological characteristics in young breast cancer patient
A single center retrospectives study in a low and middle income country
KSMO 2025
Survival Analysis of CNS patients in Bangladesh – focusing the multidisciplinary approaches among 149 patients in a single centre retrospective analysis from 2018- 2023.
Introduction: Central Nervous Tumor (CNS) tumor is variable survival status due to its location and age groups. We tried to find selected CNS tumors among adult and child with tri-modalities treatment and compared the survival and prognostic factors among 149 patients first time in Bangladesh. Methods: Retrospective analysis was done through hospital information system among CNS tumors patient’s prescription from 2018 to 2023. Follow up was also confirmed through tele conversation where the last follow up was not recent. A model with python created to analyze the survival in different groups with log rank test and COX proportional hazard ratio also tested.
Showing 5 to 6 of 6 presentations